Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2026-03-29 @ 2:54 AM
Study NCT ID:
NCT04272203
Status:
TERMINATED
Last Update Posted:
2022-09-08
First Post:
2020-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions: